ACR 2024: Preview Podcast
The IMID Forum
Exploring Guzelcomab Studies at ACR 2024
This chapter highlights the ACR 2024 meeting with a focus on guzelcomab's impact on Psoriatic Arthritis treatment. Experts present findings on treatment effectiveness, comparisons to IL-17 inhibitors, and patient-reported outcomes, illustrating guzelcomab's clinical benefits.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
